Type i interferon-dependent CD86high marginal zone precursor b cells are potent T cell costimulators in mice

Arthritis and Rheumatism

Volumn 63, Issue 4, 2011, Pages 1054-1064

  Wang, John H ^a   Wu, Qi ^a   Yang, Pingar ^a   Li, Hao ^a   Li, Jun ^a   Mountz, John D ^a   Hsu, Hui Chen ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 NITROPHENYLACETYL HAPTEN; ALPHA INTERFERON; AUTOANTIBODY; B7 ANTIGEN; CD86 ANTIGEN; CHICKEN GAMMA GLOBULIN; HAPTEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERFERON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GERMINAL CENTER; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; AUTOIMMUNITY; B-LYMPHOCYTES; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; T-LYMPHOCYTES; UP-REGULATION;

EID: 79953692403     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30231     Document Type: Article

References (32)

1. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000;9:664-71. (Pubitemid 32011791)
2. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23. (Pubitemid 36350866)
3. Nakano H, Yanagita M, Gunn MD. CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001;194:1171-8. (Pubitemid 32995786)
4. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004;5:1219-26. (Pubitemid 41057736)
5. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003;171:6466-77. (Pubitemid 37532075)
6. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, et al. The nature of the principal type 1 interferonproducing cells in human blood. Science 1999;284:1835-7.
7. Wang S, Chen L. T lymphocyte co-signaling pathways of the B7-CD28 family. Cell Mol Immunol 2004;1:37-42.
8. Wong CK, Lit LC, Tam LS, Li EK, Lam CW. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005;44:989-94. (Pubitemid 41487170)
9. Dolff S, Wilde B, Patschan S, Durig J, Specker C, Philipp T, et al. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Scand J Immunol 2007;66:584-90. (Pubitemid 47609699)
10. Liu W, Li J. Expression of CD80/CD86 and CTLA-4 mRNA in peripheral blood mononuclear cells of the patients with systemic lupus erythematosus. J Huazhong Univ Sci Technolog Med Sci 2004;24:247-9. (Pubitemid 41559625)
11. Bijl M, Horst G, Limburg PC, Kallenberg CG. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2001; 60:523-6. (Pubitemid 32417429)
12. Folzenlogen D, Hofer MF, Leung DY, Freed JH, Newell MK. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997;83:199-204. (Pubitemid 27244306)
13. Hsu HC, Zhou T, Kim H, Barnes S, Yang P, Wu Q, et al. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum 2006;54:343-55. (Pubitemid 43122218)
14. Hsu HC, Wu Y, Yang P, Wu Q, Job G, Chen J, et al. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol 2007;178:5357-65. (Pubitemid 46595322)
15. Wang JH, Li J, Wu Q, Yang P, Pawar RD, Xie S, et al. Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity. J Immunol 2010;184:442-51.
16. Srivastava B, Quinn WJ III, Hazard K, Erikson J, Allman D. Characterization of marginal zone B cell precursors. J Exp Med 2005;202:1225-34. (Pubitemid 41586953)
17. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, et al. Interleukin 17-producing T helper cells and interleukin 17 orches- trate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008;9:166-75.
18. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008;20:149-57.
19. Kraal G, Schornagel K, Streeter PR, Holzmann B, Butcher EC. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am J Pathol 1995;147:763-71.
20. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004;172:803-11. (Pubitemid 38113736)
21. Ronnblom L, Alm GV, Eloranta ML. Type I interferon and lupus. Curr Opin Rheumatol 2009;21:471-7.
22. Agrawal H, Jacob N, Carreras E, Bajana S, Putterman C, Turner S, et al. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol 2009;183:6021-9.
23. Nacionales DC, Kelly-Scumpia KM, Lee PY, Weinstein JS, Lyons R, Sobel E, et al. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 2007;56: 3770-83. (Pubitemid 350100710)
24. Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003;197:777-88. (Pubitemid 36350872)
25. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003;19:225-34. (Pubitemid 37011337)
26. Asselin-Paturel C, Brizard G, Chemin K, Boonstra A, O'Garra A, Vicari A, et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005;201:1157-67. (Pubitemid 40528442)
27. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 2004;16:915-28. (Pubitemid 38967174)
28. McKenna K, Beignon AS, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 2005;79:17-27. (Pubitemid 39648359)
29. Mirshahidi S, Huang CT, Sadegh-Nasseri S. Anergy in peripheral memory Cd4+ T cells induced by low avidity engagement of T cell receptor. J Exp Med 2001;194:719-32.
30. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev 2004;197:192-205. (Pubitemid 38142177)
31. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000;12:39-49. (Pubitemid 30069213)
32. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009;9:767-77.